Dehydrocorydaline Inhibits Cell Proliferation, Migration and Invasion via Suppressing MEK1/2-ERK1/2 Cascade in Melanoma [Corrigendum]
Hu H, Dong Z, Wang X, et al. Onco Targets Ther. 2019;12:5163–5175. The authors have advised due to an error at the time of figure assembly, Figures 2G and 4A on pages 5167 and 5169, respectively is incorrect. The correct Figures 2 and 4 are shown in Download Article. The authors apologize...
Guardado en:
Autores principales: | Hu H, Dong Z, Wang X, Bai L, Lei Q, Yang J, Li L, Li Q, Liu L, Zhang Y, Ji Y, Guo L, Liu Y, Cui H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/096f423dc9174fd8a2a0f55661ff9421 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Cerebroprotein Hydrolysate-I Plays a Neuroprotective Effect on Cerebral Ischemic Stroke by Inhibiting MEK/ERK1/2 Signaling Pathway in Rats
por: Ren Y, et al.
Publicado: (2021) -
Involvement of the ERK MAPK Cascade in the Formation of Adhesions in the Abdominal Cavity
por: I. A. Shurygina, et al.
Publicado: (2021) -
Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
por: Huihua Zeng, et al.
Publicado: (2021) -
Fisetin targets YB-1/RSK axis independent of its effect on ERK signaling: insights from in vitro and in vivo melanoma models
por: Mario Sechi, et al.
Publicado: (2018) -
IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma
por: Hima Patel, et al.
Publicado: (2021)